Enova International, Inc.'s SEC filings document its online financial services business, public-company governance and financing arrangements used by lending subsidiaries. Recent 8-K reports cover operating results and amendments to receivables-backed facilities associated with OnDeck and NetCredit entities, including revolving loan commitments, note issuance arrangements and securitization facility terms.
Proxy materials describe board matters, shareholder voting items, executive compensation, equity awards and incentive-plan disclosures. Other material-event filings record management-transition compensation arrangements, capital-structure disclosures and obligations arising from amended credit facilities.
Sean Rahilly, General Counsel and Secretary of Enova International, Inc. (ENVA), reported a sale of 2,965 shares of common stock on 08/28/2025 at a reported price of $122.635 per share. Following the transaction, Rahilly beneficially owns 100,877 shares. The Form 4 was signed on 09/02/2025 and contains no derivative transactions or additional explanatory text.
Enova International, Inc. amended its secured asset-backed revolving credit facility on August 28, 2025 by entering into a Third Amendment with Bank of Montreal and other lenders. The amendment increases the total commitment from $665,000,000 to $825,000,000, giving the company a larger borrowing capacity. It also extends the facility’s maturity date from June 30, 2026 to August 28, 2029, providing a longer-term funding source. In addition, the interest margin is reduced from the base rate plus 0.75% to the base rate plus 0.50% and from the SOFR rate plus 3.50% to the SOFR rate plus 3.25%, lowering borrowing costs. The agreement keeps the existing financial and other covenants, including limits on additional debt and leverage ratios.
Enova International, Inc. (ENVA) Form 144 shows a proposed sale of 10,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $1,210,000.00 and an approximate sale date of 08/29/2025 on the NYSE. The securities were acquired on 02/12/2019 by stock option from Enova International. Recent reported sales by the same account (David Fisher) in the past three months total 32,000 shares with gross proceeds of $3,090,958.57 across four transactions dated 06/20/2025, 07/14/2025, 08/26/2025 and 08/28/2025. Certain filer and issuer contact fields in the filing appear blank or not provided in the extract.
Form 144 notice for Enova International, Inc. (ENVA) reports a proposed sale of 2,965 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $363,612.78. The shares represent part of the issuer's outstanding common stock of 25,012,613 shares and are scheduled for sale on 08/28/2025 on the NYSE. The shares were acquired as restricted stock from the issuer on 02/23/2019 and payment was recorded as Not Applicable. The filer states there were no securities sold in the past three months for the account to be sold. Certain filer identification fields (CIK/CCC and submission contact details) are not provided in the document.
Enova International insider transaction by CEO David Fisher: The filing shows Mr. Fisher, who is both Chief Executive Officer and a director, completed offsetting transactions on 08/26/2025. He acquired 5,000 shares via exercise at an exercise price of $23.96, bringing his beneficial ownership to 353,223 shares. On the same date he sold 5,000 shares under a Rule 10b5-1 plan at a weighted average price of $117.8003, reducing post-transaction shares to 348,223. The sale executed in multiple trades at prices between $114.27 and $118.57. The filing also discloses the structure and vesting of related options and limited SARs and notes the option vesting schedule in 2020–2022.
Enova International insider sale notice under Rule 144: The filing reports a proposed sale of 15,000 shares of Enova common stock through Merrill Lynch on or about 08/28/2025, with an aggregate market value of $1,815,000 (implying $121.00 per share). The shares were acquired on 02/12/2019 via stock options granted by Enova International. The filer, identified in related sales as David Fisher at a Chicago address, sold 2,000 shares on 06/20/2025, 5,000 on 07/14/2025, and 5,000 on 08/28/2025 for total gross proceeds of $1,361,515.97. The company has 25,012,613 shares outstanding per the form. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 compliance language.
Enova International, Inc. Form 144 notice shows a proposed sale of 5,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $575,000, to be sold approximately on 08/26/2025 on the NYSE. The filer indicates these 5,000 shares were originally acquired on 02/12/2019 from Enova International via stock options. The filing also discloses two recent sales by the same person within the past three months: 2,000 shares sold on 06/20/2025 for $196,762.87 and 5,000 shares sold on 07/14/2025 for $575,951.66. The form includes a representation that the seller does not possess undisclosed material adverse information and references Rule 10b5-1 planning language.
Enova International (ENVA) reported a proposed insider sale of 17,000 common shares, with an aggregate market value of $1,849,549. The shares were acquired and paid for by the seller on 08/12/2025 through a stock option exercise, with payment made in cash. The intended sale is to be executed the same day through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists 25,012,613 shares outstanding for the issuer and shows no sales in the past three months by the selling person. The notice includes the seller's representation that they do not possess undisclosed material information. Several filer identification fields (CIK and filer name) are left blank in this document.